http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Can, Omer,Belgin, Ezgi Eren,Aycik, Gul Asiye Korean Nuclear Society 2021 Nuclear Engineering and Technology Vol.53 No.5
In this study, isophtalic neopentyl glycol polyester (NPG-PES) based composites with different loading ratios of pure tungsten metal (W), tungsten (VI) oxide (WO<sub>3</sub>), tungsten boron (WB) and tungsten carbide (WC) composites were prepared as alternative shielding materials for ionizing electromagnetic radiation (IEMR) shielding. Structural characterizations of the composites were done. Gamma spectrometric analysis of composites for 80-2000 keV energy range was performed and their usability as IEMR shielding was discussed. As a result, the produced composites showed a shielding performance of 60-100% of the lead (the most widely used IEMR shielding material) depending on the reinforcement material, reinforcement loading rate and experimental conditions. Thus, it was reported that produced composites could be an alternative to lead shieldings that have several disadvantages as toxic properties, difficulty of processing and inelasticity.
Reduced-Dose Systemic Fibrinolysis in Massive Pulmonary Embolism: A Pilot Study
Aykan Ahmet Çağrı,Gökdeniz Tayyar,Gül İlker,Kalaycıoğlu Ezgi,Karabay Can Yücel,Boyacı Faruk,Hatem Engin,Weingart Scott D.,Dursun İhsan 대한응급의학회 2023 Clinical and Experimental Emergency Medicine Vol.10 No.3
Objective: Severe pulmonary embolism (PE) has a high mortality rate, which can be lowered by thrombolytic therapy (TT). However, full-dose TT is associated with major complications, including life-threatening bleeding. The aim of this study was to explore the efficacy and safety of extended, low-dose administration of tissue plasminogen activator (tPA) on in-hospital mortality and outcomes in massive PE. Methods: This was a single-center, prospective cohort trial at a tertiary university hospital. A total of 37 consecutive patients with massive PE were included. A peripheral intravenous infusion was used to administer 25 mg of tPA over 6 hours. The primary endpoints were in-hospital mortality, major complications, pulmonary hypertension, and right ventricular dysfunction. The secondary endpoints were 6-month mortality and pulmonary hypertension and right ventricular dysfunction 6 months after the PE. Results: The mean age of the patients was 68.76±14.54 years. The mean pulmonary artery systolic pressure (PASP; 56.51±7.34 mmHg vs. 34.16±2.81 mmHg, P<0.001) and right/left ventricle
Gokhan Yildiz,Gevher Rabia Genc Perdecioglu,Damla Yuruk,Ezgi Can,Omer Taylan Akkaya 대한통증학회 2023 The Korean Journal of Pain Vol.36 No.4
Background: Genicular nerve neurolysis with phenol and radiofrequency ablation (RFA) are two interventional techniques for treating chronic refractory knee osteoarthritis (KOA) pain. This study aimed to compare the efficacy and adverse effects of both techniques. Methods: Sixty-four patients responding to diagnostic blockade of the superior medial, superior lateral, and inferior medial genicular nerve under ultrasound guidance were randomly divided into two groups: Group P (2 mL phenol for each genicular nerve) and Group R (RFA 80°C for 60 seconds for each genicular nerve). The numeric rating scale (NRS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were used to evaluate the effectiveness of the interventions. Results: RFA and phenol neurolysis of the genicular nerves provided effective analgesia within groups at 1 week, 1 month, and 3 months compared to baseline. There was no significant difference between the groups in terms of NRS and WOMAC scores at all measurement times. At the 3rd month follow-up, 50% or more pain relief was observed in 53.1% of patients in Group P and 50% of patients in Group R. The rate of transient paresthesia was 34.4% in Group P and 6.3% in Group R, and this was significantly higher in Group P. Conclusions: Neurolysis of the genicular nerves with both RFA and phenol is effective in the management of KOA pain. Phenol may be a good alternative to RFA. Further studies are needed on issues such as dose adjustment to prevent transient paresthesia response.